Serotonin Transporter Dysregulation in Depression

Robert Y. Moore

University of Pittsburgh

Funded in January, 1996: $ for 4 years
LAY SUMMARY . BIOGRAPHY . HYPOTHESIS . SELECTED PUBLICATIONS .

INVESTIGATOR BIOGRAPHIES

back to top
Robert Y. Moore

Professor of Neurology, Psychiatry and Neuroscience
University of Pittsburgh

HYPOTHESIS

back to top

Hypothesis:
The pathophysiology of depression is characterized by alterations in the function of the serotonin transporter, which can be elucidated using positron emission tomography (PET).

Goals:
To validate the use of a new PET ligand for the serotonin transporter and apply it to a preliminary study of transporter binding in untreated, newly-diagnosed patients with unipolar depression in comparison to controls.

Methods:
The PET imaging was performed using a Siemens/CTI ECAT HR+ tomograph in the 3D mode using the serotonin transporter ligand, [11C]McN5652, with a region of interest analysis that included the raphe nuclei and multiple cortical areas. Results: There is a reduction of binding to the serotonin transporter in all areas analyzed, including the cell body area of the raphe and terminal areas in the cerebral cortex.

Follow-on Funding:

NIH MH-61566   Sleep-Guided PET Studies in Depression   2/1/01-1/31/05   $1,000,000

Pittsburgh Foundation  PET Studies of Depression in Parkinson's Disease   1/1/99-6/30/02   $150,000

SELECTED PUBLICATIONS

back to top

Meltzer C.C., Smith G., DeKosky S.T., Pollock B.G., Mathis C.A., Moore R.Y., Kupfer D.J., and Reynolds C.F. III. Serotonin in aging, late-life depression and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology. 1998 Jun;18(6):407-30.

Nofzinger E.A., Nichols T.E., Meltzer C.C., Price J., Steppe D.A., Miewald J.M., Kupfer D.J., Moore R.Y. Changes in forebrain function from waking to REM sleep in depression: preliminary analysis of [18F] DG PET studies. Psychiatry Res. 1999 Aug 31;91(2):59-78.